Our findings showed that AR treatment could significantly reduce the ratio of Aβ1‐42/Aβ1‐40 and induced autophagy activation via regulating AMPK‐mTOR signaling, supporting that AR treatment improved AD cognitive impairment at least partially through autophagy activation‐mediated Aβ elimination. The gene discussed is AR; the disease is Cognitive impairment.